WHO calls for Expressions of Interest in developing Sabin-IPV

Safe and affordable inactivated polio vaccine for low-income countries

The World Health Organization’s Global Polio Eradication Initiative (WHO/POL) is looking for Expressions of Interest from private or public sector vaccine manufacturers in developing countries interested in collaborating with WHO and Intravacc in the development, manufacture and distribution of a safe effective and affordable Sabin Inactivated Polio Vaccine (sIPV), that can be produced securely in developing country settings.

Related


Related News

   13/04/2022
With wild polio at lowest levels in history, SAGE also turns focus on post-eradication
   30/03/2022
High-level summit held to take urgent action to end polio in country
   10/02/2022
From a remote village in Malawi called Chinthenche to Zambia, Ethiopia, Nigeria, and finally the WHO Regional Office for Africa.
   24/02/2021
As we approach International Women’s Day, GPEI honours two women without whom we would not be where we are
   13/11/2020
Nouvel outil à utiliser pour lutter contre le PVDVc2
   13/11/2020
WHO has issued an Emergency Use Listing recommendation for the type 2 novel oral polio vaccine (nOPV2)